ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
-
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic launched Claude Life Sciences for research using AI
On Oct. 20, 2025, Anthropic announced a new service called Claude of Life Sciences that uses artificial intelligence…
-
Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
-
Diagnostics | Disease | FDA | Medicine | Pharmaceutical | Therapeutics
FDA unveils drugs to receive expedited review in support of ‘national priorities’
On Oct. 16, 2025, the Food and Drug Administration (FDA) announced the first round of experimental drugs that…
-
AstraZeneca announces historic agreement with US Government to lower the cost of medicines for American patients
On Oct. 10, 2025, AstraZeneca announced a historic agreement with President Donald J. Trump’s administration to lower the…
-
Nobel Prize for Chemistry awarded to Susumu Kitagawa, Richard Robson, and Omar M. Yaghi
On Oct. 8, 2025, The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in…
-
Eli Lilly to invest over $1 billion in India to expand manufacturing capacity
On Oct. 5, 2025, Eli Lilly ill invest more than $1 billion in India in the coming years…
-
FDA Announces New ANDA Prioritization Pilot to Support U.S. Generic Drug Manufacturing and Testing
On Oct. 3, 2025, the U.S. Food and Drug Administration (FDA) announced a new pilot prioritization program for…
-
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
On Sept. 30, 2025, Pfizer announced an agreement with the White House that will ensure U.S. patients pay…
-
Lilly and Alexandria Real Estate opens Gateway Labs site in San Diego to boost local biotechnology ecosystem
On Sept. 26, 2025, Eli Lilly and announced the official opening of its newest Lilly Gateway Labs (LGL)…
-
Glaukos Breaks Ground on New Research, Development, and Manufacturing Facility in Huntsville, Alabama
On Sept. 25, 2025, Glaukos, an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…
-
Lilly plans to build a new $6.5 billion facility to manufacture active pharmaceutical ingredients in Texas
On Sept. 23, 2025, Eli Lilly announced that it plans to build a new $6.5 billion manufacturing facility…
-
Variational AI Enters $349 Million Collaboration with Merck to Apply Generative AI to Drug Discovery
On Sept. 23, 2025, Variational AI a generative AI drug discovery company, announced a collaboration with Merck to…
-
Celltrion unit pays $330 million for Eli Lilly production facility, filing shows
On Sept. 22, 2025, Celltrion said in a regulatory filing in South Korea its U.S. subsidiary has acquired…
-
GSK to invest $30 billion in R&D and Manufacturing in the U.S. over next 5 years
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
-
Lilly announces plans to build $5 billion manufacturing facility in Virginia
On Sept. 16, 2025, Eli Lilly announced that it plans to build a $5 billion manufacturing facility just…
-
Merck to scrap London drug research centre
On Sept. 10, 2025, Merck announced it was scrapping research operations in London, citing the UK’s challenging business…
-
Lilly launches TuneLab platform to give biotech companies access to AI-enabled drug discovery models with over $1 billion in research investment
On Sept. 9, 2025, Eli Lilly announced the launch of Lilly TuneLab, an artificial intelligence and machine learning…
-
Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement
On Sept. 2, 2025, Arrowhead Pharmaceuticals announced a global licensing and collaboration agreement with Novartis for ARO-SNCA, Arrowhead’s…
-
MannKind to Acquire scPharmaceuticals for $360 million
On Aug. 25, 2025, MannKind and scPharmaceuticals announced the signing of a definitive merger agreement for MannKind to…
-
Johnson & Johnson to Invest $2 Billion at State-Of-The-Art North Carolina Facility
On Aug. 21, 2025, Johnson & Johnson announced it will increase its presence in North Carolina with a…
-
Artificial Intelligence | Biotechnology | Infectious Disease | Medical Device | Nanotechnology | Pharmaceutical
China creates new visa for young STEM talent in national tech drive
On Aug. 14, 2025, China announced it had launched a new visa category for young science and technology…
-
AbbVie Announces $195 Million Investment to Expand Active Pharmaceutical Ingredient Manufacturing in Illinois
On Aug. 12, 2025, AbbVie announced a $195 million investment in its North Chicago, Illinois manufacturing plant to…
-
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
Aug. 1, 2025, Mallinckrodt and Endo announced that they have completed their merger to create a global, scaled,…
-
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer
On Aug. 1, 2025, the Mayo Clinic announced it had treated the first person in the U.S. using…
-
Biology | Biotechnology | Diagnostics | FDA | Imaging | Marine Science | Medical Device | Pharmaceutical
Horseshoe Crabs Break Free from Biomedical Testing
On Jul. 29, 2025, The Scientist reported that for 40 years, researchers relied on horseshoe crab blood to…
-
Biotechnology | CMO | Medical Device | Medicine | Pharmaceutical | Vaccine
Simtra BioPharma Solutions Announces Strategic Purchase to Expand U.S. Manufacturing Capacity for Injectable Medicines
On Jul. 25, 2025, Simtra BioPharma announced the purchase from Cook Group of a 65-acre property (301 N….
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
On Jul. 22, 2025, AstraZeneca announces $50 billion of investment in the United States by 2030, building on…
-
Artificial Intelligence | Biotechnology | Chemistry | Clinical Research | Diagnostics | Genomics | Imaging | Infectious Disease | Medical Device | Medicine | Pharmaceutical
International Experts Urge Collective Action to Address Emerging AIxBio Risks
On Jul. 17, 2025, More than 35 leading experts highlight the risks posed by rapidly advancing capabilities at…
-
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
On Jul. 7, 2025, KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has approved EKTERLY® (sebetralstat),…
